Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Company dna cabinet lavoix
no operation time available
1229.44
4 offices
active in Legal Services

We have observed 1 EP application Aude Veinante has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11306709

Novel therapeutic use of p75 receptor antagonists

IPC classification:
A61K 31/497, A61K 31/498, A61K 31/506, A61P 13/10
Applicant:
Sanofi, S.A.
Agent:
Aude Veinante, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature